168 related articles for article (PubMed ID: 17785994)
21. [Comprehensive treatment of bone metastases of breast cancer: a clinical analysis of 70 cases].
Zhou J; Zhang Q; Lu H
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):284-6. PubMed ID: 11038760
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
Le Scodan R; Stevens D; Brain E; Floiras JL; Cohen-Solal C; De La Lande B; Tubiana-Hulin M; Yacoub S; Gutierrez M; Ali D; Gardner M; Moisson P; Villette S; Lerebours F; Munck JN; Labib A
J Clin Oncol; 2009 Mar; 27(9):1375-81. PubMed ID: 19204198
[TBL] [Abstract][Full Text] [Related]
23. Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.
Broom R; Du H; Clemons M; Eton D; Dranitsaris G; Simmons C; Ooi W; Cella D
J Pain Symptom Manage; 2009 Aug; 38(2):244-57. PubMed ID: 19364633
[TBL] [Abstract][Full Text] [Related]
24. [IKARUS Project--incidence of bone events in breast cancer: retrospective analysis of patients in oncological centres in the Czech Republic and Slovakia].
Fínek J; Prausová J; Cmejlová V; Cwiertka K; Svébisová H; Vyzula R; Holánek M; Bodorová M; Slavícek L; Kubecová M; Loukotková L; Neumanová R; Lepeyová K; Lysý M; Smejkal J; Soumarová R; Rysková J; Kalisová K; Machanová J; Bohusová M; Alaksa V; Stresko M; Samanová T; Kůta M; Vanásek J; Vondrácková K; Vargovcíková M; Petera J; Pritzová E; Bednarík O; Hlavácová A; Jancoková I; Szeghöová O; Dammak A; Lesková J; Chroust K; Dusek L
Klin Onkol; 2009; 22(4):154-62. PubMed ID: 19731877
[TBL] [Abstract][Full Text] [Related]
25. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.
Niang U; Kamer S; Ozsaran Z; Haydaroglu A; Kilciksiz S
J BUON; 2009; 14(2):245-9. PubMed ID: 19650174
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
27. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant M; Dubsky P; Fitzal F; Blaha P; Schoppmann S; Steger G; Marth C; Samonigg H; Hüttner K; Fohler H; Ruecklinger E; Jakesz R; Greil R;
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S18-27. PubMed ID: 19561003
[TBL] [Abstract][Full Text] [Related]
28. [Current use of bisphosphonates in clinical oncology].
Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
[TBL] [Abstract][Full Text] [Related]
29. [Bone metastasis in breast carcinoma].
Kölbl O; Kiricuta IC; Willner J; Flentje M
Zentralbl Chir; 1997; 122(2):97-102. PubMed ID: 9173765
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate.
Kijima T; Fujii Y; Suyama T; Okubo Y; Yamamoto S; Masuda H; Yonese J; Fukui I
BJU Int; 2009 Mar; 103(5):620-4. PubMed ID: 18990143
[TBL] [Abstract][Full Text] [Related]
31. Clinical benefits and considerations of bisphosphonate treatment in metastatic bone disease.
Saad F; Lipton A
Semin Oncol; 2007 Dec; 34(6 Suppl 4):S17-23. PubMed ID: 18068486
[TBL] [Abstract][Full Text] [Related]
32. On the horizon: can bisphosphonates prevent bone metastases?
Coleman R
Breast; 2007 Dec; 16 Suppl 3():S21-7. PubMed ID: 17988867
[TBL] [Abstract][Full Text] [Related]
33. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary metastases of breast cancer. When is resection indicated?
Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of bone metastases with bisphosphonates].
Gremaud M; Delouche D; Monnerat C
Rev Med Suisse; 2006 Aug; 2(75):1861-6. PubMed ID: 16948423
[TBL] [Abstract][Full Text] [Related]
36. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
Gligorov J; Lotz JP
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of endocrine therapy and chemotherapy for bone metastasis of breast cancer].
Yan M; Song ST; Jiang ZF; Zhang SH; Liu XQ; Xu JM; Wang T; Luo WD
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):177-80. PubMed ID: 15196443
[TBL] [Abstract][Full Text] [Related]
39. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome.
Ryan CJ; Weinberg V; Rosenberg J; Fong L; Lin A; Kim J; Small EJ
J Urol; 2007 Dec; 178(6):2372-6; discussion 2377. PubMed ID: 17936834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
